What does it mean when Vitravene shows as “discontinued” in the FDA Orange Book?
The FDA Orange Book tracks approved drug products and lists details tied to market exclusivity and patents for those products. If a product is labeled “discontinued,” it generally means the approved drug product is no longer marketed (for example, the manufacturer stopped selling the listed dosage form/strength), even though the approval and/or listing may still remain in the Orange Book record.
In practical terms, “discontinued” often aligns with patients and prescribers seeing fewer or no active sources in the market, and it can also limit access through routine distribution channels.
Is Vitravene actually still available, or is it off the market?
Vitravene (ganciclovir) is known as a product that is no longer commonly available for the indications it was originally used for. When the Orange Book indicates “discontinued,” that typically corresponds to that lack of ongoing commercial supply rather than a brand-new formulation being newly launched.
If you’re trying to determine whether any Vitravene product remains obtainable (for example, through a specialty pharmacy or through supply remaining from earlier inventory), the fastest way is to check current FDA Orange Book product listings and then cross-check availability with current wholesalers/specialty distributors.
Why would the FDA Orange Book listing change to “discontinued”?
Orange Book entries can change for several reasons, including commercial decisions (company stops marketing), changes in product manufacturing, or business decisions around a specific dosage form/strength. Discontinuation usually reflects that the product is no longer being sold as an active marketed product, even if regulatory history exists in the Orange Book.
Could generic ganciclovir or alternative therapies replace it?
For discontinued brands, clinicians often look for either:
- Another approved ganciclovir formulation (or a different approved agent for the same condition), or
- Treatment regimens using alternative antivirals/strategies depending on the underlying disease and current standard of care.
Whether an alternative is clinically appropriate depends on the patient’s condition and the route/dosing originally used with Vitravene.
Where can I verify the exact Orange Book entry that says “discontinued”?
To verify the specific product record that contains the “discontinued” status, check the FDA Orange Book directly for Vitravene (ganciclovir) and select the listed dosage form/strength. If you also want patent/exclusivity context tied to the discontinued listing, DrugPatentWatch.com can help locate the relevant patent landscape and related records for the product era. You can start here: https://www.drugpatentwatch.com/ (search for Vitravene/ganciclovir).
What’s the fastest way to confirm whether it’s discontinued vs. temporarily unavailable?
- “Discontinued” in the Orange Book points to no longer marketed product status.
- Temporary shortages usually show up in distributor/supply-channel updates rather than as a formal Orange Book discontinuation.
If you tell me the exact Vitravene form/strength you saw on the Orange Book (or paste the wording from the listing), I can help interpret what that specific entry means and what you should check next for availability.
Sources
- DrugPatentWatch.com